How different are luminal A and basal breast cancers?
Open Access
- 9 October 2008
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 124 (6) , 1338-1348
Abstract
Heterogeneity of breast cancer makes its evolution difficult to predict, and its treatment far from being optimal. At least 5 main molecular subtypes exist. Two major subtypes are luminal A and basal subtypes, which have opposite features, notably survival. To characterize these 2 subtypes better, with the hope of better understanding their different biology and clinical outcome, we have profiled a series of 138 tumours (80 luminal A and 58 basal) using Affymetrix whole‐genome DNA microarrays. We have identified 5,621 probe sets as differentially expressed between the 2 subtypes in our series. These differences were validated in 6 independent public series (more than 600 tumours) profiled using different DNA microarrays platforms. Analysis of functions and pathways related to these probe sets, and the extent of the observed differences, confirmed that the 2 subtypes represent very distinct entities. Genes associated with proliferation, cell cycle, cell motility, angiogenesis, and NFkB signalling were overexpressed in basal tumours. Genes involved in fatty acid metabolism, TGFB signalling, and oestrogen receptor (ER) signalling were overexpressed in luminal A samples. Half of the genes overexpressed in luminal tumours contained ER‐binding sites. The number of differentially expressed genes was as high as the set of genes discriminating 2 cancers of different anatomical origin (breast and colon) or discriminating acute myeloid and lymphoid leukaemia. We provide a comprehensive list of genes/pathways that define potential diagnostic, prognostic and therapeutic targets for these 2 subtypes, which should be treated differently given the profound differences observed at the molecular level.Keywords
This publication has 88 references indexed in Scilit:
- INTEGRATIVE BIOLOGY OF PROSTATE CANCER PROGRESSIONAnnual Review of Pathology: Mechanisms of Disease, 2006
- Identification of new classes among acute myelogenous leukaemias with normal karyotype using gene expression profilingOncogene, 2004
- Repeated observation of breast tumor subtypes in independent gene expression data setsProceedings of the National Academy of Sciences, 2003
- Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profilesProceedings of the National Academy of Sciences, 2002
- Multiclass cancer diagnosis using tumor gene expression signaturesProceedings of the National Academy of Sciences, 2001
- MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemiaNature Genetics, 2001
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001
- Molecular portraits of human breast tumoursNature, 2000
- Systematic variation in gene expression patterns in human cancer cell linesNature Genetics, 2000
- Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression MonitoringScience, 1999